KBio Inc: Clinical Trials

5 trials sponsored by KBio Inc, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 4 Phase 1, 1 Early Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Early Phase 11Completed 1
Phase 21Completed 1

Follow KBio Inc: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 1, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of an Enterovirus D68-specific Monoclonal Antibody in Healthy Adults
EV68-228-N, Placebo for EV68-228-N - Enterovirus Infection
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)362024-06-262026-05-04
An Exploratory Study of ZB-06 as a Vaginal Contraceptive Film
ZB-06 - Contraception
Early Phase 1CompletedKBio Inc202021-02-082025-01-15
KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers
Low Dose of KBP-COVID-19, High Dose of KBP-COVID-19, Placebo - Covid19
Phase 1 / Phase 2CompletedKBio Inc1022020-12-302025-05-18
Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults
Low dose, Intermediate dose, High dose - Influenza
Phase 1CompletedKBio Inc1202020-06-252021-09-16
Safety Study of Monoclonal Antibodies to Reduce the Vaginal Transmission of HSV and HIV
MB66, Placebo Film - HIV, Herpes Simplex Infections
Phase 1CompletedKBio Inc382016-01-012023-11-14

Conditions studied

COVID-19 (1)  ·  Enterovirus Infections (1)  ·  Herpes Simplex (1)  ·  Influenza, Human (1)

Interventions

Contraceptives, Oral (1)

Countries

United States (5)  ·  Canada (1)

Top investigators

Barry Bratcher (1)  ·  Brandon Essink, MD (1)  ·  Hugh Haydon (1)

Results publications

PMID 33534791, PMID 36870409, PMID 40126012

NIH funding

5UM1AI148684-04 (1), U19AI096398 (1)